SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial "SILENT"

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

Introduction: Patients with atrial fibrillation (AF) have a substantial risk of stroke and systemic embolism. Subclinical AF is often suspected to be the cause of stroke in these patients. The detection of asymptomatic AF episodes is a challenge and the real rate of occurrence of these episodes remains unknown. The rate of stroke is high among patients who have received a pacemaker and this device can detect...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 September 2014.

1 Feb 2015 24 Sep 2013 1 Oct 2020 1 Oct 2020 1 Sep 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available